Form D · Pharmaceuticals

Thetis Pharmaceuticals LLC

Deep River, CT · CIK 0001528491

Offering snapshot reported Oct 13, 2026 · SEC filing

Reported sold
$560K
Offering amount: $1M
Investors reported
10
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Aug 13, 2026
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 13, 2026Initial$560,300No comparison10SEC filing
Jul 11, 2022Initial$1,098,320No comparison9SEC filing
Aug 7, 2018Initial$795,800No comparison8SEC filing
Jan 17, 2017Amendment$4,105,495$771,644vs Jun 27, 201652SEC filing
Jun 27, 2016Initial$3,333,851No comparison22SEC filing
Feb 11, 2016Initial$1,434,000No comparison16SEC filing
Dec 18, 2012Initial$5,665,730No comparison32SEC filing
Aug 26, 2011Initial$1,535,000No comparison14SEC filing

Offering details

Securities
Debt, Option to acquire
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0 (estimated)
Finders' fees
$0 (estimated)
Form D file number
021-600869

Source: Form D, filed Oct 13, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Michael Carter Executive
Fabio Cataldi Director
David Cook Director
Cynthia Green Director
Gary Mathias Director, Executive
Alan Mendelson Director
Walter Ogier Director
Frank C. Sciavolino Director
Dennis Willson Director
David M Wurzer Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
80 Meadows Road
Deep River, CT, 06417